Abstract
Late stent thrombosis (LST) and very LST (VLST) are infrequent complications after drug-eluting stent (DES) implantation, but they carry a significant risk for patients. Delayed healing, which may be represented by incomplete stent coverage, has been observed in necropsy vessel specimens treated with DES. As a result, in vivo assessment of stent coverage, as well as stent apposition using optical coherence tomography (OCT), have been recently used as surrogate safety endpoints in clinical trials testing DES platforms. By adopting strut coverage assessed by OCT, one can assess the safety profile of the new generation of DES in preregistration studies. This article focuses on stent strut coverage as a central predictor of late DES thrombosis from the histopathological point of view, discusses the limitations of the current imaging modalities and presents the technical characteristics of OCT for the detection of neointimal coverage after stent implantation. We also review the preclinical and clinical investigations using this novel imaging modality.
Similar content being viewed by others
Abbreviations
- OCT:
-
Optical coherence tomography
- DES:
-
Drug-eluting stent
- IVUS:
-
Intravascular ultrasound
- SES:
-
Sirolimus-eluting stent
- PES:
-
Paclitaxel-eluting stent
- ZES:
-
Zotarolimus-eluting stent
- UA:
-
unstable angina
- SA:
-
Stable angina
- CTO:
-
Chronic total occlusion
- MACE:
-
Major cardiovascular event
- MI:
-
Myocardial infarction
- AMI:
-
Acute myocardial infarction
- LST:
-
Late stent thrombosis
- OLP:
-
Overlap
- TLR:
-
Target lesion revascularization
- AUC:
-
Area under the receiver operating characteristic curve
- PCI:
-
Percutaneous coronary intervention
- NIH:
-
Neointimal hyperplasia
- TD-OCT:
-
Time-domain optical coherence tomography
- FD-OCT:
-
Fourier-domain optical coherence tomography
- TVR:
-
Target vessel revascularization
- NSTACS:
-
Non-ST elevation acute coronary syndrome
- CAD:
-
Coronary artery disease
- CI:
-
Confidence interval
- BMS:
-
Bare metal stent
- PI:
-
Principle investigator
- EES:
-
Everolimus-eluting stent
- BAS:
-
Bio-active stent
- DEB:
-
Drug-eluting balloon
- BES:
-
Biolimus-eluting stent
References
Morice MC, Serruys PW, Sousa JE et al (2002) Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. RAVEL study group. N Engl J Med 346:1773–1780
Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. TAXUS-IV investigators. N Engl J Med 350:221–231
Sousa JE, Costa MA, Abizaid A et al (2003) Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative angiography and three-dimensional intravascular ultrasound study. Circulation 107:24–27
Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D et al (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. A randomized controlled trial. JAMA 294:1215–1223
Thuesen L, Kelbaek H, Kløvgaard L et al (2006) Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the stenting coronary arteries in non-stress/Benestent disease trial (SCANDSTENT). Am Heart J 152:1140–1145
Pasceri V, Patti G, Speciale G et al (2007) Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 153:749–754
Baumgart D, Klauss V, Baer F et al (2007) One-year results of the SCORPIUS study. A german multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. J Am Coll Cardiol 50:1627–1634
Camenzind E, Steg PG, Wijns W (2007) Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115:1440–1455
Daemen J, Wenawesser P, Tsuchida K, Abrecht L, Vaina S, Morger C et al (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667–678
Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L, SCAAR Study Group (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009–1019
Farb A, Heller PF, Shroff S et al (2001) Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104:473–479
Guagliumi G, Farb A, Musumeci G et al (2003) Images in cardiovascular medicine: sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation 107:1340–1341
Sousa JE, Costa MA, Farb A et al (2004) Images in cardiovascular medicine: vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histophatological examination. Circulation 110:e5–e6
Virmani R, Guagliumi G, Farb A et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701–705
Joner M, Finn AV, Farb A et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202
Luscher TF, Steffel J, Eberli FR et al (2007) Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115:1051–1058
Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441
Nakazawa G, Finn AV, Joner M et al (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118:1138–1145
Guagliumi G, Sirbu V (2008) Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv 72:237–247
Tanigawa J, Barlis P, Di Mario C et al (2007) Intravascular optical coherence tomography: optimization of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 3:128–136
Bezerra HG, Costa MA, Guagliumi G et al (2009) Intracoronary optical coherence tomography: a comprehensive review: clinical and research applications. JACC Cardiovasc Interv 2:1035–1046
Joner M, Nakazawa G, Finn AV et al (2008) Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 52:333–342
Klugherz BD, Llanos G, Lieuallen W et al (2002) Twenty-eight-day efficacy and pharmacokinetics of the sirolimus-eluting stent. Coron Artery Dis 13:183–188
Suzuki T, Kopia G, Hayashi S et al (2001) Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104:1188–1193
Carter AJ, Aggarwal M, Kopia GA et al (2004) Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in porcine coronary model. Cardiovasc Res 63:617–624
Regar E, Werner F, Siebert U et al (2000) Reproducibility of neointima quantification with motorized intravascular ultrasound pullback in stented coronary arteries. Am Heart J 139:632–637
Cook S, Wenaweser P, Togni M et al (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115:2426–2434
Alfonso F, Suárez A, Pérez-Vizcayno MJ et al (2007) Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 50:2095–2097
Lee CW, Kang SJ, Park DW et al (2010) Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 55:1936–1942
Hassan AK, Bergheanu SC, Stijnen T et al (2010) Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 31:1172–1180
Fujii K, Carlier SG, Mintz GS et al (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after drug-eluting stent implantation. An intravascular ultrasound study. J Am Coll Cardiol 45:995–998
Okabe T, Mintz GS, Buch AN, Roy P et al (2007) Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 100:615–620
Lermusiaux P, Martinez R, Donadey A et al (2000) Intravascular ultrasound: limitations and prospects. J Mal Vasc 25:229–236
Di Mario C, Gorge G, Peters R et al (1998) Clinical application and image interpretation in intracoronary ultrasound. Study group on intracoronary imaging of the working group of coronary circulation and of the subgroup on intravascular ultrasound of the working group of echocardiography of the european society of cardiology. Eur Heart J 19:207–229
Di Mario C, Barlis P (2008) Optical coherence tomography: a new tool to detect tissue coverage in drug-eluting stents. JACC Cardiovasc Interv 1:174–175
Matsumoto D, Shite J, Shinke T et al (2007) Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28:961–967
Sera F, Awata M, Uematsu M et al (2009) Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy. JACC Cardiovasc Interv 2:989–994
Kotani J, Awata M, Nanto S et al (2006) Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47:2108–2111
Higo T, Ueda Y, Oyabu J et al (2009) Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. JACC Cardiovasc Imaging 2:616–624
Awata M, Kotani J, Uematsu M et al (2007) Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 116:910–916
Prati F, Zimarino M, Stabile D et al (2008) Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology on a rabbit carotid model. Heart 94:217–294
Murata A, Wallace-Bradley D, Tellez A et al (2010) Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging 3:76–84
Suzuki Y, Ikeno F, Koizumi T et al (2008) In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. JACC Cardiovasc Interv 1:168–173
Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno A, Valsecchi O, Biondi-Zoccai G, Costa MA (2010) Optical coherence tomography assessment of in vivo vascular response following implantation of overlapping bare-metal and drug-eluting stents. JACC Cardivasc Interv 3:531–539
Guagliumi G, Sirbu V, Costa MA, Musumeci G, Trivisonno A, Matiashvili A, Lortkipanidze N, Mihalcsik L, Valsecchi O, Bezerra HG, Suzuki N, Coletta J, Mintz G, Maehara A, Parise H, Lansky A, Cristea E, Mehran R, Stone G (2011) Long-term strut coverage of paclitaxel eluting stents compared to bare-metal stents implanted during primary PCI in acute myocardial infarction: HORIZONS-OCT. Circulation 123:274–281
Guagliumi G, Sirbu V, Bezerra HG, Zoccai GB, Fiocca L, Musumeci G, Matiashvili A, Lortkipanidze N, Tahara S, Valsecchi O, Costa MA (2010) Strut coverage and vessel wall response to zotarolimus-eluting and bare metal stents implanted in patients with ST-elevation myocardial infarction: the OCTAMI (optical coherence tomography in acute myocardial infarction) study. JACC Cardiovasc Interv 3:680–687
Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H, Fiocca L, Mathiasvili A, Lortkipanidze N, Vassileva A, Popma JJ, Allocco DJ, Dawkins KD, Valsecchi O, Costa MA (2010) Strut coverage and vessel wall response to a new generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: optical coherence tomography drug eluting stent investigation (OCTDESI). Circ Cardiovasc Interv 3:367–375
Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns RJ, Ferrante G, Wandel S, Windecker S, van Es GA, Eerdmans P, Jüni P, di Mario C (2010) An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J 31:165–176
Kim JS, Hong MK, Fan C, Kim TH, Shim JM, Park SM, Ko YG, Choi D, Jang Y (2010) Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study. Am Heart J 159:278–283
Murakami D, Takano M, Yamamoto M, Inami S, Ohba T, Seino Y, Mizuno K (2009) Advanced neointimal growth is not associated with a low risk of in-stent thrombus. Optical coherence tomographic findings after first-generation drug-eluting stent implantation. Circ J 73:1627–1634
Fan C, Kim JS, Lee JM, Kim TH, Park SM, Wi J, Paik SI, Ko YG, Choi D, Hong MK, Jang Y (2010) Different vascular healing patterns with various drug-eluting stents in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: optical coherence tomographic findings. Am J Cardiol 105:972–976
Kubo T, Imanishi T, Kitabata H, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Takarada S, Tanaka A, Nakamura N, Mizukoshi M, Tomobuchi Y, Akasaka T (2008) Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 1:475–484
Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, Ishikawa M, Kawai T, Takagi Y, Ishii J, Prati F, Serruys PW (2010) The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J 31:1470–1476
Kim JS, Jang IK, Kim JS, Kim TH, Takano M, Kume T, Hur NW, Ko YG, Choi D, Hong MK, Jang Y (2009) Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart 95:1907–1912
Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ, Sun SH, Guo XM, Wang F, Tian T, Chu XW (2008) Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 94:566–570
Xie Y, Takano M, Murakami D, Yamamoto M, Okamatsu K, Inami S, Seimiya K, Ohba T, Seino Y, Mizuno K (2008) Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol 102:27–31
Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D, Sawada T, Miyoshi N, Kawamori H, Yoshino N, Hirata K (2009) Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 73:1033–1037
Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897–910
Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371:899–907
Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, Dangas G, Corcos T, Prati F (2009) First-in-man 1-year clinical outcomes of the catania coronary stent system with nanothin polyzene-F in de novo native coronary artery lesions: the ATLANTA (assessment of the latest non-thrombogenic angioplasty stent) trial. JACC Cardiovasc Interv 2:197–204
Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, Ohba T, Mizuno K (2007) Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99:1033–1038
Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y (2009) Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv 2:1240–1247
Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27:1500–1510
Tian F, Chen YD, Sun ZJ, Chen L, Yuan F, Song XT, Lü SZ (2009) Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography. Chin Med J 20(122):670–674
Bezerra HG, Guagliumi G, Valescchi O, Lortkipanidze N, Rosenthal N, Tahara S, Kyono H, Simon DI, Costa MA (2009) Unraveling the lack of neointimal hyperplasia detected by IVUS using OCT: lack of spatial resolution or a true biological effect? The ODESSA sub-study. J Am Coll Cardiol 53:2523
Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T, Takemoto Y, Onoue K, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y (2009) Long-term follow-up of neointimal coverage of sirolimus-eluting stents—evaluation with optical coherence tomography. Circ J 73:2300–2307
Bezerra HG, Guagliumi G, Kyono H, Tahara S, Rosenthal N, Musumeci G, Sirbu V, Valescchi O, Aprile A, Simon DI, Costa MA (2009) Determining the optimal cross-sectional analysis interval for OCT assessment of coronary stenting. Circulation 120:S1000
Yao ZH, Matsubara T, Inada T, Suzuki Y, Suzuki T (2008) Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chin Med J 121:503–507
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tahara, S., Chamié, D., Baibars, M. et al. Optical coherence tomography endpoints in stent clinical investigations: strut coverage. Int J Cardiovasc Imaging 27, 271–287 (2011). https://doi.org/10.1007/s10554-011-9796-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-011-9796-3